Richard E. Uihlein
Director at Galectin Therapeutics. Based in Norcross, Georgia.
- Rank
- 1056th of 14,644
- Companies held
- 1
- Largest holding
- GALT, 100.0% of total
- Latest SEC filing
- Jul 31, 2026
- Listed but not counted
- $80K
What the $159M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Galectin Therapeutics GALT Common Stock | Richard E. Uihlein Stock Trust | 44,713,843 | $2.89 | $129M | 81.2% | Form 4, Jul 31, 2026 |
| Galectin Therapeutics GALT Common Stock | Directly | 10,332,676 | $2.89 | $29.8M | 18.8% | Form 4, Jan 16, 2026 |
Share counts are the amounts Richard E. Uihlein reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Richard E. Uihlein's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Galectin Therapeutics GALT Common Stock | Through Ed Uihlein Family Foundation Held for a foundation or charity | 27,710 | $2.89 | $80K | — | Form 4, Jul 31, 2026 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1053 | Scott Arthur Beck President and CEO, Gloo Holdings. Boulder, CO | $160M |
| 1054 | Steven Nielsen CEO, Dycom Industries. Phoenix, AZ | $160M |
| 1055 | David Abraham Gilboa Co-Chief Executive Officer, Warby Parker. New York, NY | $159M |
| 1056 | Richard E. Uihlein Director, Galectin Therapeutics. Norcross, GA | $159M |
| 1057 | Howard D. Elias CCO & Pres., Svcs. & Digital, Dell Technologies. Round Rock, TX | $159M |
| 1058 | Alexander D. Moore Director, Palantir Technologies. Aventura, FL | $159M |
| 1059 | Tricia Glynn Director, First Watch Restaurant Group. Boston, MA | $158M |
Questions
How much stock does Richard E. Uihlein own?
Richard E. Uihlein holds $158,809,207 in listed stock based on SEC filings and current prices, mostly Galectin Therapeutics (GALT). That ranks 1056th on the Stock Rich List.
Is this Richard E. Uihlein's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.